Shanghai Henlius Biotech, Inc. (2696.HK)

HKD 40.35

(3.59%)

Revenue Summary of Shanghai Henlius Biotech, Inc.

Shanghai Henlius Biotech, Inc.'s latest annual revenue in 2023 was 5.39 Billion CNY , up 67.82% from previous year.
Shanghai Henlius Biotech, Inc.'s latest quarterly revenue in 2024 Q2 was 1.37 Billion CNY , down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported a annual revenue of 3.21 Billion CNY in annual revenue 2022, up 91.07% from previous year.
Shanghai Henlius Biotech, Inc. reported a annual revenue of 1.68 Billion CNY in annual revenue 2021, up 186.34% from previous year.
Shanghai Henlius Biotech, Inc. reported a quarterly revenue of 1.37 Billion CNY for 2024 Q2, down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported a quarterly revenue of 5.39 Billion CNY for 2023 FY, up 67.82% from previous quarter.

Annual Revenue Chart of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Historical Annual Revenue of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Year	Revenue	Revenue Growth
2023	5.39 Billion CNY	67.82%
2022	3.21 Billion CNY	91.07%
2021	1.68 Billion CNY	186.34%
2020	587.58 Million CNY	546.2%
2019	90.92 Million CNY	1125.29%
2018	7.42 Million CNY	-78.12%
2017	33.91 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q1	1.37 Billion CNY	-6.41%
2024 Q2	1.37 Billion CNY	0.0%
2023 FY	5.39 Billion CNY	67.82%
2023 Q1	1.25 Billion CNY	15.71%
2023 Q4	1.46 Billion CNY	2.79%
2023 Q3	1.42 Billion CNY	14.17%
2023 Q2	1.25 Billion CNY	0.0%
2022 Q4	1.08 Billion CNY	27.9%
2022 Q3	844.82 Million CNY	31.04%
2022 Q2	644.69 Million CNY	0.0%
2022 Q1	644.69 Million CNY	22.93%
2022 FY	3.21 Billion CNY	91.07%
2021 Q3	524.43 Million CNY	65.54%
2021 Q2	316.79 Million CNY	0.0%
2021 Q1	316.79 Million CNY	32.78%
2021 FY	1.68 Billion CNY	186.34%
2021 Q4	524.43 Million CNY	0.0%
2020 FY	587.58 Million CNY	546.2%
2020 Q4	238.59 Million CNY	0.0%
2020 Q2	55.19 Million CNY	0.0%
2020 Q1	55.19 Million CNY	49.4%
2020 Q3	238.59 Million CNY	332.27%
2019 Q4	36.94 Million CNY	0.0%
2019 Q2	16.11 Million CNY	1644.05%
2019 Q1	924 Thousand CNY	-75.1%
2019 FY	90.92 Million CNY	1125.29%
2019 Q3	36.94 Million CNY	129.26%
2018 Q4	3.71 Million CNY	0.0%
2018 FY	7.42 Million CNY	-78.12%
2018 Q3	3.71 Million CNY	0.0%
2018 Q2	- CNY	0.0%
2018 Q1	- CNY	0.0%
2017 FY	33.91 Million CNY	0.0%

Peer Revenue Comparison of Shanghai Henlius Biotech, Inc.

Name	Revenue	Revenue Difference
Uni-Bio Science Group Limited	484.71 Million HKD	-1013.0%
CK Life Sciences Int'l., (Holdings) Inc.	5.32 Billion HKD	-1.356%